| Omnitrope | Post-Market | Small for Gestational Age |
| Levodopa/Carbidopa(200mg/50mg) | Post-Market | Impulse Control Disorder |
| LEVOFLOXACIN | Approved | |
| BUPROPION HYDROCHLORIDE | Approved | |
| OXALIPLATIN | Approved | |
| PHENDIMETRAZINE TARTRATE | Approved | |
| CLARITHROMYCIN | Approved | |
| PROPOXYPHENE HYDROCHLORIDE | Approved | |
| TAFLUPROST | Approved | |
| OFLOXACIN | Approved | |
| BRIMONIDINE TARTRATE | Approved | |
| CHLORPROPAMIDE | Approved | |
| REGONOL | Approved | |
| DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | Approved | |
| IRBESARTAN AND HYDROCHLOROTHIAZIDE | Approved | |
| AMITRIPTYLINE HYDROCHLORIDE | Approved | |
| RIVASTIGMINE | Approved | |
| HALOPERIDOL DECANOATE | Approved | |
| MECLIZINE HYDROCHLORIDE | Approved | |
| BETHANECHOL CHLORIDE | Approved | |
| HYCAMTIN | Approved | |
| BRINZOLAMIDE | Approved | |
| ZIEXTENZO | Approved | |
| PHENTERMINE HYDROCHLORIDE | Approved | |
| ENZEEVU | Approved | |
| FLUPHENAZINE HYDROCHLORIDE | Approved | |
| GRANISETRON HYDROCHLORIDE | Approved | |
| CYCLOPHOSPHAMIDE | Approved | |
| CIPROFLOXACIN HYDROCHLORIDE | Approved | |
| GP2411 | Phase 3 | Postmenopausal Women With Osteoporosis |
| GP2015 | Phase 3 | Rheumatoid Arthritis |
| LRG-002 | Phase 3 | Antibiotic-associated Diarrhea |
| Broncho-munal® | Phase 3 | Acute Uncomplicated Respiratory Tract Infections |
| HX575 epoetin alfa (Sandoz) | Phase 3 | Chronic Kidney Disease |
| EP2006 | Phase 3 | Chemotherapy Associated Neutropenia |
| SOK583A1 | Phase 3 | Neovascular Age-related Macular Degeneration (nAMD) |
| acetylcysteine | Phase 3 | Rhinosinusitis |
| GP2013 | Phase 3 | Follicular Lymphoma |
| Mometasone | Phase 3 | Seasonal Allergic Rhinitis |
| Fluticasone furoate and vilanterol inhalation powder | Phase 3 | Respiratory |
| JPB898 (Induction and Maintenance) | Phase 3 | Melanoma |
| GME751 | Phase 3 | Metastatic NSCLC |
| HX575 epoetin alfa Hexal AG | Phase 3 | Anemia |
| Azelastine + Mometazone, nasal spray | Phase 3 | Seasonal Allergic Rhinitis |
| HX575, solution for injection (s.c.) | Phase 3 | Anemia |
| HX575 solution for s.c. administration | Phase 3 | Anemia |
| GP2013 - A Proposed biosimilar rituximab | Phase 3 | Rheumatoid Arthritis |
| CYB704 | Phase 3 | Relapsing Multiple Sclerosis |
| Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals) | Phase 3 | Rhinitis, Allergic, Seasonal |
| Cefdinir 300 mg Capsule (Sandoz, Austria) | Phase 1 | Healthy |
| Eplerenone 50 mg Tablets Sandoz Inc., USA | Phase 1 | Hypertension |
| Desipramine HCl 50 mg Tablets Cord Laboratories | Phase 1 | Depression |
| Diclofenac Sodium 50 mg Tablets Under Fasting Conditions (Geneva Pharmaceuticals, Inc) | Phase 1 | Inflammation |
| Glipizide 10 mg Tablets (Geneva Pharmaceutical, Inc.) | Phase 1 | Type 2 Diabetes |
| Azithromycin Monohydrate 600mg Tablets Geneva Pharmaceuticals | Phase 1 | Infection |
| Desipramine Hydrochloride 100 mg Tablets (Cord Laboratories) | Phase 1 | Depression |
| Fentanyl patch 25 ug/nr Sandoz | Phase 1 | Pain |
| Cyclobenzaprine HCl Tablets 10 mg, Cord Laboratories | Phase 1 | Depression |
| Sevirumab | Phase 1 | Cytomegalovirus Infections |
| Atenolol (Tenormin) 100 mg Tablets Zeneca (Astra Zeneca Pharmaceutical) | Phase 1 | Angina |
| Cefprozil 250 mg/5 ml Oral Suspension (Sandoz GmbH) | Phase 1 | Healthy |
| Lisinopril 40 mg Tablet (EON Labs Manufacturing Inc, USA) | Phase 1 | Hypertension |
| Mometasone + Azelastine | Phase 1 | Seasonal Allergic Rhinitis |
| Olaparib tablets, 150 mg | Phase 1 | Ovarian Cancer |
| Budesonide | Phase 1 | |
| Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | Phase 1 | Rheumatoid Arthritis |
| Haloperidol 10 mg Tablets (Cord Laboratories) | Phase 1 | Psychosis |
| Fluoxetine HCl 20 mg Capsules Under Fasting Conditions (Geneva Pharmaceutical, Inc.) | Phase 1 | Depression |
| Sargramostim | Phase 1 | HIV Infections |
| Metformin HCL 500 mg Extended-Release Tablets, Geneva PTC | Phase 1 | Type II Diabetes |
| Levetiracetam Tablets, 750 mg (Sandoz Inc.) | Phase 1 | Seizure |
| Indomethacin 75mg Extended-Release Capsules, Sandoz | Phase 1 | Inflammation |
| Naproxen Delayed Release Tables, 375 (Gevena Pharmaceuticals, Inc.) | Phase 1 | Rheumatoid Arthritis |
| Cetirizine HCl/Pseudoephedrine HCl 5 mg/120 mg Tablets (Sandoz, USA) | Phase 1 | Allergies |
| Octreotide | Not Applicable | Diarrhea |